Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-5.56%
↑ 25% above average
Average (8y)
-7.41%
Historical baseline
Range
High:-1.66%
Low:-14.48%
CAGR
+16.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -5.56% | +32.8% |
| 2023 | -8.28% | +32.6% |
| 2022 | -12.28% | -50.7% |
| 2021 | -8.15% | +43.7% |
| 2020 | -14.48% | -87.4% |
| 2019 | -7.73% | -37.1% |
| 2018 | -5.63% | -95.9% |
| 2017 | -2.88% | -72.9% |
| 2016 | -1.66% | - |